LYNFENSO
Live / Registered — Registered (as of 09 Jan 2024)
What this means for you
Registered since 09 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97717042
- Registration number
- 7268792
- Mark type
- Stylized text
- Filed
- 14 Dec 2022
- Published for opposition
- 24 Oct 2023
- Registered
- 09 Jan 2024
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 09 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Oct 2023 — PUBLISHED FOR OPPOSITION
- 04 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Sept 2023 — ASSIGNED TO EXAMINER
- 12 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Mar 2023 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 02 Mar 2023 — ASSIGNED TO LIE
- 19 Dec 2022 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 19 Dec 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Dec 2022 — NEW APPLICATION ENTERED